ArticleLeukemia2024
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells.
Nabih Maslah et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleLeukemia2024
Nabih Maslah et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.